Viewing Study NCT05746377



Ignite Creation Date: 2024-05-06 @ 6:41 PM
Last Modification Date: 2024-10-26 @ 2:52 PM
Study NCT ID: NCT05746377
Status: RECRUITING
Last Update Posted: 2023-07-11
First Post: 2023-02-08

Brief Title: Metoclopramide in Upper Gastrointestinal Bleed
Sponsor: Mercy Health System
Organization: Mercy Health System

Study Overview

Official Title: Premedication With Metoclopramide in Upper Gastrointestinal Bleeds a Prospective Double Blinded Single Center Randomized Control Trial in a Small Community Hospital
Status: RECRUITING
Status Verified Date: 2023-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to test if metoclopramide can improve effectiveness of endoscopic intervention in upper gastrointestinal GI bleeds The main questions the investigators hope to answer is

Does metoclopramide lessen the need for repeat endoscopy interventional radiology intervention or surgery in cases of upper GI bleed

Does metoclopramide improve visibility of the GI walls in cases of upper GI bleed
Detailed Description: The purpose of the study is to see if giving metoclopramide prior to an endoscopy in cases of upper GI bleed can decrease the need for repeat endoscopy due to poor visibility Metoclopramide stimulates stomach and intestine activity It is used to treat nausea vomiting and slow gut movement The investigators are testing if metoclopramides effect on stimulating stomach activity can lead to more effective emptying of blood from the stomach and upper intestines in upper GI bleeding so physicians conducting endoscopies can easily see the stomach and intestinal wall and treat the source of bleeding

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: True
Is an FDA AA801 Violation?: None